SUJAY KANGO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SUJAY KANGO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SUJAY KANGO. SUJAY KANGO is Chief Commercial Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and EVP, Chief Commercial Officer in ACCELERON PHARMA INC ($XLRN) and SVP, Chief Commercial Officer in ACCELERON PHARMA INC ($XLRN).
Latest Insider Trading Transactions of SUJAY KANGO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Option Exercise | M | 40.61 | 5,000 | 203,050 | 35,000 | |
| Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 138.15 | 200 | 27,630 | 19,396 | 19.6 K to 19.4 K (-1.02 %) |
| Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 137.12 | 600 | 82,272 | 19,596 | 20.2 K to 19.6 K (-2.97 %) |
| Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 136.24 | 1,501 | 204,496 | 20,196 | 21.7 K to 20.2 K (-6.92 %) |
| Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 135.48 | 2,699 | 365,661 | 21,697 | 24.4 K to 21.7 K (-11.06 %) |
| Mar 04 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Buy | M | 40.61 | 5,000 | 203,050 | 24,396 | 19.4 K to 24.4 K (+25.78 %) |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Option Exercise | A | 115.53 | 20,896 | 2,414,115 | 20,896 | |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Grant | A | 0.00 | 5,409 | 0 | 19,396 | 14 K to 19.4 K (+38.67 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 126.15 | 4,624 | 583,318 | 3,987 | 8.6 K to 4 K (-53.70 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 125.17 | 3,429 | 429,208 | 8,611 | 12 K to 8.6 K (-28.48 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 123.90 | 1,947 | 241,233 | 12,040 | 14 K to 12 K (-13.92 %) |
| Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Payment of Exercise | F | 124.31 | 1,357 | 168,689 | 13,987 | 15.3 K to 14 K (-8.84 %) |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Option Exercise | A | 52.99 | 24,334 | 1,289,459 | 24,334 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Grant | A | 0.00 | 6,369 | 0 | 15,939 | 9.6 K to 15.9 K (+66.55 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Sell | S | 51.27 | 11 | 564 | 9,570 | 9.6 K to 9.6 K (-0.11 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Sell | S | 51.37 | 469 | 24,093 | 9,581 | 10.1 K to 9.6 K (-4.67 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Sell | S | 51.27 | 11 | 564 | 9,570 | 9.6 K to 9.6 K (-0.11 %) |
| Jan 03 2020 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Sell | S | 51.37 | 469 | 24,093 | 9,581 | 10.1 K to 9.6 K (-4.67 %) |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Option Exercise | A | 41.64 | 25,500 | 1,061,820 | 25,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Grant | A | 0.00 | 4,050 | 0 | 10,050 | 6 K to 10.1 K (+67.50 %) |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Option Exercise | A | 40.61 | 50,000 | 2,030,500 | 50,000 | |
| Feb 13 2018 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | SVP, Chief Commerci ... | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.25 | 7,676 | 9,623 | 599 | 8.3 K to 599 (-92.76 %) |
| Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.27 | 42,017 | 53,248 | 8,275 | 50.3 K to 8.3 K (-83.55 %) |
| Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.30 | 298 | 387 | 50,292 | 50.6 K to 50.3 K (-0.59 %) |
| Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.30 | 25,009 | 32,612 | 50,590 | 75.6 K to 50.6 K (-33.08 %) |
| Nov 02 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Grant | A | 0.00 | 75,000 | 0 | 75,599 | 599 to 75.6 K (+12,520.87 %) |
| Jan 08 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Option Exercise | A | 6.71 | 60,000 | 402,600 | 60,000 | |
| Apr 01 2015 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Option Exercise | A | 13.98 | 200,000 | 2,796,000 | 200,000 |
Page: 1